glp 1 gip dual agonist mechanism of action GLP-1/GIP | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) Science Behind GLP 1 GIP
Description
R., He, Y.,
Paper not available as full text
Psychological factors, including unfulfilled expectations and identity changes after marked weight loss, compound these risks [29]
CagriSema is intended for once-weekly subcutaneous treatment
Adverse psychiatric effects associated with GLP-1 RAs, including depression, anxiety, and suicidal ideation, are noted in pharmacovigilance analyses, with variations among different GLP-1 RAs
Some combinations are used in clinical practice
